NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Overview Fund Activity
Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

11 hedge funds and large institutions have $482K invested in Northwest Biotherapeutics, Inc. Common stock in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.

Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MSAM
1
Moloney Securities Asset Management
Missouri
$321K

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
MSAM
1
Moloney Securities Asset Management
Missouri
$321K 352,660 +23,000 +7%
OCG
2
Opus Capital Group
Ohio
$55K 60,150 – –
WJWM
3
Williams Jones Wealth Management
New York
$40K 44,000 – –
MCM
4
MAI Capital Management
Ohio
$18.2K 20,000 – –
LDB
5
Lee, Danner & Bass
Tennessee
$18K 20,000 – –
AA
6
AlphaMark Advisors
Kentucky
$13K 14,007 – –
AMG
7
Advisors Management Group
Wisconsin
$9K 10,270 – –
BC
8
Bartlett & Co
Ohio
$4K 4,292 – –
BCWM
9
Bartlett & Co Wealth Management
Ohio
$3.9K 4,292 – –
HFS
10
Hantz Financial Services
Michigan
$0 250 – –
CMP
11
Coston McIsaac & Partners
Maine
$0 1,000 +1,000 New